AS

Ann Marie Schmidt

CU Columbia University: 30 patents #14 of 2,492Top 1%
NU New York University: 4 patents #170 of 1,640Top 15%
SF SUNY Research Foundation: 4 patents #68 of 1,165Top 6%
CC Cleveland Clinic: 2 patents #284 of 972Top 30%
📍 Franklin Lakes, NJ: #7 of 205 inventorsTop 4%
🗺 New Jersey: #1,729 of 69,400 inventorsTop 3%
Overall (All Time): #97,905 of 4,157,543Top 3%
35
Patents All Time

Issued Patents All Time

Showing 1–25 of 35 patents

Patent #TitleCo-InventorsDate
11730737 Aldose reductase inhibitors and uses thereof Andrew WASMUTH, Donald W. Landry, Shixian Deng, Banavara L. Mylari, Ravichandran Ramasamy 2023-08-22
11529349 Aldose reductase inhibitors and uses thereof Andrew WASMUTH, Donald W. Landry, Shixian Deng, Banavara L. Mylari, Ravichandran Ramasamy 2022-12-20
11192859 Quinoline compounds as modulators of RAGE activity and uses thereof Ravichandran Ramasamy, Alexander Shekhtman, Vivek Rai, Michaele B. Manigrasso 2021-12-07
10729695 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof Ravichandran Ramasamy, Alexander Shekhtman, Vivek Rai, Michaele B. Manigrasso 2020-08-04
10639306 Aldose reductase inhibitors and uses thereof Andrew WASMUTH, Donald W. Landry, Shixian Deng, Banavara L. Mylari, Ravichandran Ramasamy 2020-05-05
10265320 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof Ravichandran Ramasamy, Alexander Shekhtman, Vivek Rai, Michaele B. Manigrasso 2019-04-23
10052324 Aldose reductase inhibitors and uses thereof Andrew WASMUTH, Donald W. Landry, Shi-Xian Deng, Banavara L. Mylari, Ravichandran Ramasamy 2018-08-21
9650383 Aldose reductase inhibitors and uses thereof Andrew WASMUTH, Donald W. Landry, Shi-Xian Deng, Banavara L. Mylari, Ravichandran Ramasamy 2017-05-16
9364472 Amino, Amido and heterocyclic compounds as modulators of RAGE activity and uses thereof Ravichandran Ramasamy, Alexander Shekhtman, Vivek Rai, Michaele B. Manigrasso 2016-06-14
9353078 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof Ravichandran Ramasamy, Alexander Shekhtman, Vivek Rai, Michaele B. Manigrasso 2016-05-31
8133866 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury David M. Stern, Steven Marso, Eric Topol, A. Michael Lincoff 2012-03-13
8124829 Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof David M. Stern, Shi Du Yan 2012-02-28
8067371 RAGE G82S-related methods and compositions for treating inflammatory disorders David M. Stern 2011-11-29
7919670 Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof David M. Stern, Shi Du Yan 2011-04-05
7732400 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury David M. Stern, Steven Marso, Eric Topol, A. Michael Lincoff 2010-06-08
7700085 Method for treating symptoms of diabetes David M. Stern 2010-04-20
7494972 Method for inhibiting accelerated atherosclerosis in a subject suffering from hypercholesterolemia or hypertriglyceridemia David M. Stern 2009-02-24
7258857 Rage-related methods for treating inflammation David M. Stern, Kevan C. Herold, Shi Du Yan, Ira Lamster 2007-08-21
7125675 Method for inhibiting tumor invasion or spreading in a subject David M. Stern 2006-10-24
7101838 Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts David M. Stern 2006-09-05
7081241 Extracellular rage binding protein (EN-RAGE) and uses thereof David M. Stern 2006-07-25
7026444 Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof David M. Stern 2006-04-11
6825164 Method to increase cerebral blood flow in amyloid angiopathy David M. Stern, Shi Du Yan, Berislav Zlokovic 2004-11-30
6790443 Method for treating symptoms of diabetes David M. Stern 2004-09-14
6753150 Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rage David M. Stern 2004-06-22